106 related articles for article (PubMed ID: 20189896)
1. [C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and adipocytokine levels in the morbidly obese].
De Luis DA; González Sagrado M; Aller R; Izaola O; Conde R; Romero E
Endocrinol Nutr; 2010 Feb; 57(2):54-9. PubMed ID: 20189896
[TBL] [Abstract][Full Text] [Related]
2. Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets.
Deluis DA; Sagrado MG; Aller R; Izaola O; Conde R
Metabolism; 2010 Sep; 59(9):1387-92. PubMed ID: 20102775
[TBL] [Abstract][Full Text] [Related]
3. C358A missense polymorphism of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) and visfatin levels in obese females.
de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R; Romero E
Int J Obes (Lond); 2010 Mar; 34(3):511-5. PubMed ID: 20065978
[TBL] [Abstract][Full Text] [Related]
4. Relation of Trp64Arg polymorphism of beta3-adrenoreceptor gene with cardiovascular risk factors in presurgical morbidly obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez-Sagrado M; Conde R
Arch Med Res; 2008 Nov; 39(8):791-5. PubMed ID: 18996293
[TBL] [Abstract][Full Text] [Related]
5. The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women.
Monteleone P; Tortorella A; Martiadis V; Di Filippo C; Canestrelli B; Maj M
Psychoneuroendocrinology; 2008 May; 33(4):546-50. PubMed ID: 18295974
[TBL] [Abstract][Full Text] [Related]
6. Relation of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) with obesity and insulin resistance.
de Luis DA; González Sagrado M; Aller R; Izaola O; Conde R
Nutr Hosp; 2010; 25(6):993-8. PubMed ID: 21519771
[TBL] [Abstract][Full Text] [Related]
7. Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss after a hypocaloric diet.
de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R
Metabolism; 2011 May; 60(5):730-4. PubMed ID: 20716455
[TBL] [Abstract][Full Text] [Related]
8. Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery.
de Luis DA; Sagrado MG; Pacheco D; Terroba MC; Martin T; Cuellar L; Ventosa M
Surg Obes Relat Dis; 2010; 6(5):516-20. PubMed ID: 20870184
[TBL] [Abstract][Full Text] [Related]
9. Relation of Trp64Arg polymorphism of beta 3-adrenergic receptor gene to adipocytokines and fat distribution in obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
Ann Nutr Metab; 2008; 52(4):267-71. PubMed ID: 18617734
[TBL] [Abstract][Full Text] [Related]
10. Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance.
de Luis DA; Aller R; Izaola O; Conde R; Sagrado MG; Primo D; Castro MJ
J Diabetes Complications; 2012; 26(4):328-32. PubMed ID: 22609216
[TBL] [Abstract][Full Text] [Related]
11. Influence of ALA54THR polymorphism of fatty acid-binding protein 2 on obesity and cardiovascular risk factors.
de Luis DA; Sagrado MG; Aller R; Izaola O; Conde R
Horm Metab Res; 2007 Nov; 39(11):830-4. PubMed ID: 17992640
[TBL] [Abstract][Full Text] [Related]
12. C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2.
de Luis DA; Sagrado MG; Aller R; Izaola O; Conde R; Romero E
Diabetes Res Clin Pract; 2010 Apr; 88(1):76-80. PubMed ID: 20056290
[TBL] [Abstract][Full Text] [Related]
13. The fatty acid amide hydrolase (FAAH) Pro129Thr polymorphism is not associated with severe obesity in Greek subjects.
Papazoglou D; Panagopoulos I; Papanas N; Gioka T; Papadopoulos T; Papathanasiou P; Kaitozis O; Papatheodorou K; Maltezos E
Horm Metab Res; 2008 Dec; 40(12):907-10. PubMed ID: 18819056
[TBL] [Abstract][Full Text] [Related]
14. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease.
Aller R; De Luis DA; Fernandez L; Calle F; Velayos B; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez JM
Eur Rev Med Pharmacol Sci; 2009; 13(5):357-64. PubMed ID: 19961041
[TBL] [Abstract][Full Text] [Related]
15. Influence of Ala54Thr polymorphism of fatty acid-binding protein-2 on clinical results of biliopancreatic diversion.
de Luis DA; Sagrado MG; Izaola O; Terroba MC; Cuellar L; Conde R; Martin T
Nutrition; 2008 Apr; 24(4):300-4. PubMed ID: 18280114
[TBL] [Abstract][Full Text] [Related]
16. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2.
De Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R; De la Fuente B
Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):89-95. PubMed ID: 20329566
[TBL] [Abstract][Full Text] [Related]
17. [G1359A polymorphism of the cannabinoid receptor gene (CNR1) on anthropometric parameters and cardiovascular risk factors in patients with morbid obesity].
Luis DA; González Sagrado M; Aller R; Izaola O; Conde R; Pérez Castrillón JL; Romero E
Nutr Hosp; 2009; 24(6):688-92. PubMed ID: 20049372
[TBL] [Abstract][Full Text] [Related]
18. G 1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of biliopancreatic diversion.
de Luis DA; Pacheco D; Aller R; Gonzalez Sagrado M; Conde R; Izaola O; Cuellar L; Terroba MC; Martin T; Ventosa M
Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):197-201. PubMed ID: 20391958
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and their influence on weight loss and insulin resistance under a high monounsaturated fat hypocaloric diet.
de Luis D; Aller R; Izaola O; Conde R; de la Fuente B; Gonzalez Sagrado M
J Diabetes Complications; 2013; 27(3):235-9. PubMed ID: 23333123
[TBL] [Abstract][Full Text] [Related]
20. Influence of Lys656Asn polymorphism of the leptin receptor gene on insulin resistance in nondiabetic obese patients.
de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R
J Diabetes Complications; 2008; 22(3):199-204. PubMed ID: 18413223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
